Medical therapy of brain edema in fulminant hepatic failure

Hepatology

Volumn 32, Issue 3, 2000, Pages 666-669

  Blei, Andres T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; AQUAPORIN; BARBITURIC ACID DERIVATIVE; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; INDOMETACIN; ORNITHINE ASPARTATE; PHENYTOIN;

ASTROCYTE; BRAIN CIRCULATION; BRAIN EDEMA; CELL SWELLING; CLINICAL TRIAL; EDITORIAL; ENZYME INDUCTION; HEPATIC ENCEPHALOPATHY; HUMAN; INDUCED HYPOTHERMIA; INTRACRANIAL HYPERTENSION; LIVER FAILURE; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

EID: 0033848885     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.17923     Document Type: Article

References (47)

1. Acute liver failure: Redefining the syndromes
2. Neurological sequelae in patients recovered from fulminant hepatic failure
3. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure
4. Effect of posture on intracranial pressure and cerebral perfusion pressure in patients with fulminant hepatic and renal failure after acetaminophen self-poisoning
5. Is there a role for continuous renal replacement therapies in patients with liver and renal failure?
6. Sub-clinical seizure activity and prophylactic phenytoin infusion in acute liver failure: A controlled clinical trial
7. Brain edema and hepatic encephalopathy
8. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure
9. Current concepts of brain edema. Review of laboratory investigations
10. Glutamine synthetase: Glial localization in brain
11. Intracellular pH rises and astrocytes swell after portacaval anastomosis in rats
12. Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat
13. Astroglial dysfunction in hepatic encephalopathy
14. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration
15. Hepatic encephalopathy in chronic liver disease: A clinical manifestation of astrocyte swelling and low-grade cerebral edema?
16. Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis
17. Tumor necrosis factor α induces astrocyte swelling
18. Effect of benzodiazepines and neurosteroids on ammonia-induced swelling in cultured astrocytes
19. Astrocytic-ammonia interactions in hepatic encephalopathy
20. Cerebral oedema and increased intracranial pressure in chronic liver disease
21. Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage
22. L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure
23. L-ornithine-L-aspartate lowers hyperammonemia and prevents encephalopathy and brain edema in acute liver failure via a post-translational increase of muscle glutamine synthetase [Abstract]
24. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke
25. Aquaporin-4 water channel is up-regulated in the brain in fulminant hepatic failure
26. Evidence for an astrocytic glutamate transporter deficit in hepatic encephalopathy
27. Swelling-activated release of excitatory amino acids in the brain: Relevance for pathophysiology
28. Hepatic encephalopathy and brain edema in acute hepatic failure: Does glutamate play a role?
29. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats
30. Cerebral circulation in liver failure: Ohm's law in force
31. Pathophysiology of cerebral edema in fulminant hepatic failure
32. Cerebral perfusion, cardiac output, and arterial pressure in patients with fulminant hepatic failure
33. Mild hypothermia modifies ammonia-induced brain edema in rats after portacaval anastomosis
34. Cerebral blood flow and the development of ammonia-induced brain edema in rats after portacaval anastomosis
35. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure
36. Mild hypothermia - A revived countermeasure against ischemic neuronal damage
37. Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure
38. Suppression of cerebral metabolic rate for oxygen (CMRO2) by mild hypothermia compared with thiopental
39. Cerebral blood flow and metabolism in fulminant liver failure
40. N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction
41. The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure
42. Indomethacin normalizes intracranial pressure in acute liver failure: A twenty-three-year-old woman treated with indomethacin
43. Indomethacin prevents the development of cerebral swelling and cerebral hyperemia in experimental ammonia-induced brain edema
44. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial
45. Protein S-100beta: A biochemical marker for increased intracranial pressure in pigs with acute hepatic failure
46. Neuronal and glial markers and their relation to cerberal herniation in fulminant hepatic failure
47. Etiology and outcome for 295 patients with acute liver failure in the United States